myelodysplastic-myeloproliferative disease

• 骨髄異形成・骨髄増殖性症候群、骨髄異形成・骨髄増殖性障害

WordNet

1. an impairment of health or a condition of abnormal functioning
2. caused by or altered by or manifesting disease or pathology; "diseased tonsils"; "a morbid growth"; "pathologic tissue"; "pathological bodily processes" (同)morbid, pathologic, pathological

PrepTutorEJDIC

1. (体の)『病気』,疾患 / (精神・道徳などの)病気,病弊
2. 女性の話術芸人 =diseur
3. 病気にかかった / 病的な,不健全な(morbid)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 骨髄異形成症候群の臨床症状および診断 clinical manifestations and diagnosis of the myelodysplastic syndromes
• 2. 中等度～低リスクまたは極めて低リスクの骨髄異形成症候群の治療 treatment of intermediate low or very low risk myelodysplastic syndromes
• 3. 骨髄増殖性腫瘍の概要 overview of the myeloproliferative neoplasms
• 4. 慢性骨髄単球性白血病 chronic myelomonocytic leukemia
• 5. 原発性骨髄線維症の臨床症状および診断 clinical manifestations and diagnosis of primary myelofibrosis

English Journal

• Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.

• Brissot E1, Cahu X, Guillaume T, Delaunay J, Ayari S, Peterlin P, Le Bourgeois A, Harousseau JL, Milpied N, Bene MC, Moreau P, Mohty M, Chevallier P.
• Annals of hematology.Ann Hematol.2015 Apr;94(4):663-9. doi: 10.1007/s00277-014-2259-x. Epub 2014 Nov 21.
• In the myeloablative transplant setting, the early use of fluconazole prophylaxis provides a benefit in overall survival. Recent changes in transplantation practices, including the use of peripheral blood stem cells (PBSC) and/or reduced intensity conditioning (RIC) regimen may have favorably impact
• PMID 25409914

• Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions-a retrospective multicenter analysis from the german cooperative transplant study group.

• Schroeder T1, Rachlis E2, Bug G3, Stelljes M4, Klein S5, Steckel NK6, Wolf D7, Ringhoffer M8, Czibere A2, Nachtkamp K2, Dienst A2, Kondakci M2, Stadler M9, Platzbecker U10, Uharek L11, Luft T12, Fenk R2, Germing U2, Bornhäuser M10, Kröger N13, Beelen DW6, Haas R2, Kobbe G2.
• Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.Biol Blood Marrow Transplant.2015 Apr;21(4):653-60. doi: 10.1016/j.bbmt.2014.12.016. Epub 2014 Dec 23.
• To expand the current knowledge about azacitidine (Aza) and donor lymphocyte infusions (DLI) as salvage therapy for relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and to identify predictors for response and survival, we retrospectively analyzed data of 154 patients with
• PMID 25540937

• Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.

• Hahm C1, Huh HJ, Mun YC, Seong CM, Chung WS, Huh J.
• International journal of laboratory hematology.Int J Lab Hematol.2015 Apr;37(2):181-9. doi: 10.1111/ijlh.12257. Epub 2014 May 21.
• INTRODUCTION: Myeloproliferative neoplasms (MPN) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) may transform into secondary myelofibrosis (MF) or evolve into acute myeloid leukemia (AML). The genetic mechanisms underlying disease progression in MPN and MDS/MPN patients remain unclear. T
• PMID 24845343

Japanese Journal

• 若年性骨髄単球性白血病７５例の予後：小児血液学会ＭＤＳ委員会の前方視的検討

• 吉田 奈央,平林 真介,渡辺 静,在家 裕司,土田 昌宏,吉見 礼美,増永 敦子,大塚 欣敏,伊藤 雅文,小島 勢二,中畑 龍俊,真部 淳
• 臨床血液 52(12), 1853-1858, 2011
• 若年性骨髄単球性白血病(JMML)は乳幼児に好発する稀な骨髄異形成／骨髄増殖性疾患であり，診断が難しいことから小児血液学会MDS委員会において前方視的登録と中央診断を行っている。今回1999年から2006年に本登録を経て診断されたJMML75例を追跡調査した。診断時年齢は中央値20ヵ月（1∼85ヵ月），染色体異常は21例に認め，うち11例がmonosomy7を有した。全体の5年生存率は60%であり …
• NAID 130004501501

• Non-Tuberculous Mycobacterial Infection Localized in Small Intestine Developing after Allogeneic Bone Marrow Transplantation

• Yamazaki Rie,Mori Takehiko,Nakazato Tomonori,Aisa Yoshinobu,Imaeda Hiroyuki,Hisamatsu Tadakazu,Hibi Toshifumi,Okamoto Shinichiro
• Internal Medicine 49(12), 1191-1193, 2010
• … A 33-year-old man with myelodysplastic/myeloproliferative disease underwent allogeneic bone marrow transplantation. …
• NAID 130000251652

Related Links

• Myelodysplastic/myeloproliferative disease | Genetic and ...

Myelodysplastic/ myeloproliferative diseases are a group of diseases of the blood and bone marrow in which the bone marrow makes too many white blood cells. These disease have features of both myelodysplastic ...

• Myelodysplastic/ Myeloproliferative Neoplasms Treatment ...

Myelodysplastic/myeloproliferative neoplasm, unclassifiable, is a disease that has features of both myelodysplastic and myeloproliferative diseases but is not chronic myelomonocytic leukemia, juvenile myelomonocytic leukemia / ...

• Myelodysplastic myeloproliferative disease - Global Genes

Myelodysplastic/myeloproliferative diseases are a group of diseases of the blood and bone marrow in which the bone marrow makes too many white blood cells. These disease have features of both myelodysplastic syndromes and ...

---

★リンクテーブル★

リンク元	「骨髄異形成・骨髄増殖性障害」「骨髄異形成・骨髄増殖性症候群」
関連記事	「disease」「myelodysplastic」

「骨髄異形成・骨髄増殖性障害」

　　[★]

英

myelodysplastic-myeloproliferative disease

関

骨髄異形成・骨髄増殖性症候群

「骨髄異形成・骨髄増殖性症候群」

　　[★]

英

myelodysplastic-myeloproliferative disease

関

骨髄異形成・骨髄増殖性障害

「disease」

　　[★]

• n.

疾患：illnessより厳密な概念。「ある臓器に明確な障害が確認され、それによって症状が出ているとはっきり説明できる場合」 (PSY.9)

特定の原因、病態生理、症状、経過、予後、病理組織所見が全てそろった場合 (PSY.9)

• something that is very wrong with people's attitudes, way of life or with society.

関

ail、ailment、disease entity、disorder、ill、illness、malady、sick、sickness

• 注意

disease ≠ illness ≠ disorder

　 　 　

「myelodysplastic」

　　[★]

• 骨髄異形成の

関

marrow dysplasia